AGER and systemic lupus erythematosus: Although there are some controversial reports [156], most research reports support that the plasma levels of sRAGE are diminished in SLE compared to healthy controls [157,158,159], thus limiting the action of this decoy receptor in arresting the inflammatory response upon RAGE engagement.